MetLife Inc. stock declined 2.3%. The company reported Q4 2025 earnings on February 5, 2026, posting earnings per share of $2.49, which exceeded analyst expectations of $2.35 by 5.96%. This represented a beat and showed an increase from $2.09 in the same quarter the previous year. The next earnings report is scheduled for April 29, 2026, with analysts projecting an EPS of $2.20. Earlier in Q3 2025, MetLife reported an EPS of $2.34 against a forecast of $2.31, but revenue fell short at $17.36 billion compared to the anticipated $18.77 billion. The company reported adjusted earnings of $1.6 billion in Q3, a 22% increase year-over-year, with a 16.7% adjusted return on equity.
Read full analysisMetLife Inc. stock declined 2.3%. The company reported Q4 2025 earnings on February 5, 2026, posting earnings per share of $2.49, which exceeded analyst expectations of $2.35 by 5.96%. This represented a beat and showed an increase from $2.09 in the same quarter the previous year. The next earnings report is scheduled for April 29, 2026, with analysts projecting an EPS of $2.20. Earlier in Q3 2025, MetLife reported an EPS of $2.34 against a forecast of $2.31, but revenue fell short at $17.36 billion compared to the anticipated $18.77 billion. The company reported adjusted earnings of $1.6 billion in Q3, a 22% increase year-over-year, with a 16.7% adjusted return on equity.
MetLife is one of the largest global insurance and financial services companies, offering life insurance, annuities, employee benefits, and asset management to roughly 100 million customers across more than 40 countries. The company beat Q4 2025 earnings estimates by 6% on February 5, posting adjusted EPS of $2.49. MetLife is currently experiencing an unexplained two-day selloff totaling roughly 8%, significantly underperforming both the financials sector and direct insurance peers with no identified catalyst.